Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Apoptosis | R-HSA-109581 | map04210 | ribavirin | 2123 | drug-path |
| Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | ribavirin | 2123 | drug-path |
| Renal cell carcinoma | R-HSA-9794523 | map05211 | ribavirin | 2123 | drug-path |
| B cell receptor signaling pathway | R-HSA-983705 | map04662 | ribavirin | 2123 | drug-path |
| Insulin signaling pathway | R-HSA-74752 | map04910 | ribavirin | 2123 | drug-path |
| Fc epsilon RI signaling pathway | R-HSA-2454202 | map04664 | ribavirin | 2123 | drug-path |
| Type II diabetes mellitus | R-HSA-2127377 | map04930 | ribavirin | 2123 | drug-path |
| Renal cell carcinoma | R-HSA-9794523 | map05211 | AH-23848 | 5733 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | AH-23848 | 5733 | drug-path |
| Wnt signaling pathway | R-HSA-195721 | map04310 | AH-23848 | 5733 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | AH-23848 | 5733 | drug-path |
| Non-small cell lung cancer | R-HSA-5619066 | map05223 | AH-23848 | 5733 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | AH-23848 | 5733 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | AH-23848 | 5733 | drug-path |
| Cell cycle | R-HSA-1640170 | map04110 | AH-23848 | 5733 | drug-path |
| Thyroid cancer | R-HSA-9700206 | map05216 | AH-23848 | 5733 | drug-path |
| Jak-STAT signaling pathway | R-HSA-168638 | map04630 | AH-23848 | 5733 | drug-path |
| Complement and coagulation cascades | R-HSA-114591 | map04610 | AH-23848 | 5733 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | isotretinoin | 5282379 | drug-path |
| Alzheimer's disease | R-HSA-1643685 | 0 | isotretinoin | 5282379 | drug-path |